ストックスクリーナーアプリを入手
3.25
1.56%
0.05
前日終値:
$3.20
開ける：
$3.4499
24時間の取引高:
39,408
Relative Volume:
0.95
時価総額：
$112.33M
収益：
$24.99M
当期純損益:
$-65.24M
株価収益率:
-1.1364
EPS:
-2.86
ネットキャッシュフロー:
$-21.27M
1週間 パフォーマンス:
+11.30%
1か月 パフォーマンス:
-32.85%
6か月 パフォーマンス:
-18.75%
1年 パフォーマンス:
-18.55%
1日の値動き範囲:
$3.15
$3.4499
1週間の範囲:
$2.96
$3.4499
52週間の値動き範囲:
$2.28
$5.24
Elutia Inc Stock (ELUT) Company Profile
ELUT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
3.25 | 112.33M | 24.99M | -65.24M | -21.27M | -2.86 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-11-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-02 | 開始されました | Cowen | Outperform |
| 2020-11-02 | 開始されました | Piper Sandler | Overweight |
| 2020-11-02 | 開始されました | Truist | Buy |
Elutia Inc (ELUT) 最新ニュース
Elutia announces full U.S. commercial launch of EluPro - Yahoo Finance
Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand - The Manila Times
Elutia Inc. Announces Full Launch of EluPro? Following Strong Initial Demand - Marketscreener.com
Elutia Inc. (NASDAQ:ELUT) Stock Position Lifted by Geode Capital Management LLC - Defense World
Elutia secures deal to supply antibiotic bioenvelope By Investing.com - Investing.com Australia
Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners - The Manila Times
Elutia secures deal to supply antibiotic bioenvelope - Investing.com
Elutia's Revolutionary EluPro Antibiotic Device Gains Access to 993 Healthcare Facilities - StockTitan
Elutia Inc. (NASDAQ:ELUT) Not Doing Enough For Some Investors As Its Shares Slump 27% - Simply Wall St
Are Medical Stocks Lagging ELUTIA INC (ELUT) This Year? - Yahoo Finance
Elutia (NASDAQ:ELUT) Trading 1.9% HigherHere's Why - MarketBeat
Elutia (NASDAQ:ELUT) Trading Up 1.9% – Here’s Why - Defense World
Elutia awarded cardian rhythm management devices agreement with Premier - TipRanks
Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc. - The Manila Times
ELUTElutia Inc. Latest Stock News & Market Updates - StockTitan
Elutia Inc. (NASDAQ:ELUT) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St
Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cantor Fitzgerald Reaffirms Overweight Rating for Elutia (NASDAQ:ELUT) - Defense World
Elutia's (ELUT) "Overweight" Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Elutia Inc (ELUT) Q3 2024 Earnings Call Highlights: Strategic Gr - GuruFocus.com
Elutia Inc (ELUT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges By GuruFocus - Investing.com Canada
Elutia Inc. (ELUT) Quarterly 10-Q Report - Quartzy
Elutia Inc. Reports Strong Q3 Results, Prepares for Major Product Launch - TipRanks
Elutia Inc (ELUT) Q3 2024 Earnings: EPS of $0.03 Beats Estimates, Revenue of $5.92M Misses Expectations - GuruFocus.com
Elutia earnings beat by $0.11, revenue fell short of estimates - Investing.com UK
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025 - The Manila Times
Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - The Manila Times
What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings - GuruFocus.com
Elutia (ELUT) to Release Earnings on Thursday - Defense World
Elutia (ELUT) Set to Announce Earnings on Thursday - MarketBeat
Short Interest in Elutia Inc. (NASDAQ:ELUT) Rises By 7.4% - MarketBeat
Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024 - The Manila Times
Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30 - The Manila Times
Individual investors among Elutia Inc.'s (NASDAQ:ELUT) largest stockholders and were hit after last week's 10% price drop - Simply Wall St
Contaminated donor tissue gave Georgia patient tuberculosis, lawsuit says - The Atlanta Journal Constitution
SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc - GuruFocus.com
Preclinical Data Show Efficacy Of Elutia's Antibiotic-Eluting BioEnvelope - MPO-mag
Preclinical Data Show Efficacy of Elutia’s Antibiotic-Eluting BioEnvelope - MPO-mag
Elutia (NASDAQ:ELUT) vs. Curis (NASDAQ:CRIS) Head to Head Comparison - Defense World
Nantahala Capital Management LLC Grows Stock Position in Elutia Inc. (NASDAQ:ELUT) - Defense World
Nantahala Capital Management LLC Purchases 145,697 Shares of Elutia Inc. (NASDAQ:ELUT) - MarketBeat
Short Interest in Elutia Inc. (NASDAQ:ELUT) Declines By 30.1% - MarketBeat
Elutia Inc. (NASDAQ:ELUT) Sees Large Decrease in Short Interest - Defense World
Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices - StockTitan
Short Interest in Elutia Inc. (NASDAQ:ELUT) Decreases By 10.9% - MarketBeat
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators - HMP Global Learning Network
Elutia announces first patient implant of EluPro, the world’s first drug-eluting bioenvelope for cardiac pacemakers and neurostimulators - Cardiovascular Business
AIGH Capital Management LLC Increases Position in Elutia Inc. (NASDAQ:ELUT) - MarketBeat
Cantor Fitzgerald Reiterates “Overweight” Rating for Elutia (NASDAQ:ELUT) - Defense World
Elutia Celebrates First Year - ForexTV.com
Elutia Inc (ELUT) 財務データ
収益
当期純利益
現金流量
EPS
3.55%
大文字化:
|
ボリューム (24 時間):